Key data

GENERAL CONTRACTOR: KARMAR
INVESTOR: Tarchomińskie Zakłady Farmaceutyczne POLFA SA
DESIGN OFFICE: Exyte Central Europe

TOTAL AREA: 11 594 m2

PROJECT COMPLETION: 2024

Description

Project covers the second stage of construction of the building of the Sterile Forms Production Department and the R&D Laboratories, along with the communication system around the building and internal installations, on the premises of the production plant of Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.

Karmar has been selected as the general contractor for the building and installation of
a new lyophilization department, Highly Potent Drug Manufacturing and R&D laboratory with equipment.